Drug class
Selective alpha-1 adrenergic receptor antagonist; peripheral vasodilator
Mechanism of action
Antagonises postsynaptic alpha-1 adrenoceptors, particularly alpha-1A receptors, reducing catecholamine-mediated vascular smooth-muscle contraction and promoting peripheral vasodilation.
General use cases
- Historically used for peripheral circulatory disorders including Raynaud’s phenomenon in countries where authorised.
- Topical ophthalmic use has been described to reverse sympathomimetic-induced mydriasis; formulation and authorisation are jurisdiction-specific.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
